Emerging market equities are at risk due to newly proposed U.S. tariffs, which could raise average tariffs on imports to 24% by 2024, the highest since the 1920s. UBS warns that these tariffs, not yet priced into the market, may lead to downward revisions in expected earnings growth for the MSCI Emerging Markets Index, as 13% of its revenue comes from the U.S. and now faces a 35% tariff. The firm highlights potential impacts on global trade and economic growth, with emerging market currencies likely to weaken against the U.S. dollar.